Direxion Daily S&P Biotech Bull 3X ETF
LABU
47 hedge funds and large institutions have $18.8M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 19 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
0.03% less ownership
Funds ownership: 0.14% → 0.11% (-0.03%)
8% less funds holding
Funds holding: 51 → 47 (-4)
21% less call options, than puts
Call options by funds: $13.2M | Put options by funds: $16.6M
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
31% less capital invested
Capital invested by funds: $27.3M → $18.8M (-$8.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$2.62M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.8M |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$1.28M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$706K |
| 5 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$591K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.2M |
| 2 |
Squarepoint
New York
|
-$1.37M |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$569K |
| 4 |
Morgan Stanley
New York
|
-$507K |
| 5 |
G
Gainplan
Bloomfield Hills,
Michigan
|
-$444K |
LABU Hedge Fund Activity: Q3 2023 in Review
47 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2023, worth a combined $18.8M — down 31% from $27.3M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of LABU and 15 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 16 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $2.62M. The largest seller was Citadel Advisors, cutting an estimated $3.2M.
- 47 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2023, down from 51 in Q2 2023.
- Funds reported $18.8M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2023, down 31% quarter-over-quarter.
- 15 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2023 and 19 closed out, a net change of -4 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2023 was HRT Financial, an estimated $2.62M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2023 was Citadel Advisors, an estimated $3.2M sold.
Based on aggregated 13F filings for Q3 2023.